Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. - Wikidata - wikimedia - TriplyDB

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.

http://www.wikidata.org/entity/Q34166215

about

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans Uncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancer The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer Cancer Biology, Toxicology and Alternative Methods Development Go Hand-in-Hand A dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cells miRDeep*: an integrated application tool for miRNA identification from RNA sequencing data.MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samples The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells - A data description Exploiting Epigenetic Alterations in Prostate Cancer.Androgen receptor and its splice variants in prostate cancer Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells.Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin are targets of miR-644a.PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo Silencing KRAS overexpression in arsenic-transformed prostate epithelial and stem cells partially mitigates malignant phenotype.Complex modulation of androgen responsive gene expression by methoxyacetic acid.MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.Multiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathway Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.MicroRNAs and Androgen Receptor 3' Untranslated Region: A Missing Link in Castration-resistant Prostate Cancer?Epigenetic regulation of prostate cancer Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway.Regulators of gene expression as biomarkers for prostate cancer Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer.Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs.Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma.MiR-654-5p attenuates breast cancer progression by targeting EPSTI1.Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells

P2860

Q26739708-AD632E6D-3228-4ADB-88A2-02E883B0D559 Q26774456-1EC1D229-C6E2-499D-B0F6-D2BBF5637732 Q26795625-139EC808-75FB-4516-AC0E-86A7FC0A3E35 Q27008271-2D269729-70F0-44C3-9400-DD1DA539E66C Q27014171-ADEDDC64-279A-4F16-A5EA-D31573A1ACCF Q28468629-D4AEFA5E-6217-43A6-8B77-B118A9BC682E Q28549191-C924D48F-01EC-4990-AF82-826EE5C8E49A Q28573536-E97DC5D1-55B8-4119-8262-78B21F1D18D1 Q30580665-BBBB1A0D-A2E4-4792-B93F-0064924CB605 Q30859743-A6D20E50-C78A-48AB-BAAC-5DFB85BFD360 Q31008419-69551D5B-33EB-456B-80FE-BAA41E8FFBDF Q33755160-47A99F36-717B-458D-B478-C2AA1B0D3178 Q34199684-AAFB6F45-5787-4476-9097-E1D8A42C503D Q34425208-A2F84EA9-2B2A-44BD-8D60-B140FB0CE1D0 Q34444017-FD283F69-ED9B-4A14-ACFA-49025CD9A79B Q34455289-4C4A317E-6DA5-4C04-9C49-FED31A32F8E5 Q34468270-8ADCCB81-93CC-4F18-B0F8-06A13B62E68D Q34501681-0131A64E-C993-4266-AF1C-D9664438BCEA Q34606029-E03FB5CC-3C5B-4970-A4B6-C1A107944BFB Q34871216-CE8C7760-4849-43ED-B85E-87052DF49E50 Q34948292-F4290DE5-987A-4AD1-9AA7-5FDE5BCD462B Q35024073-4852BF20-5586-4F9E-AF86-58A137AE707E Q35097232-230D032A-3B62-4229-9A56-CF6BE8E9581A Q35744695-E245C7ED-C0A0-4B77-8B4C-5606B9F14C61 Q35809301-B30B732C-9CEF-4BE4-BEDD-1850CB9C538B Q35861506-99BFD9AA-1B1C-41C2-82BA-26B7A172843C Q36001910-0D56CDE8-9543-45B6-B3DD-285A5B033F76 Q36067934-C3293773-5CC7-4628-B536-070955B02B61 Q36146986-84509BBD-862B-4F2B-A46A-C89C5DDC33A3 Q36147506-958ACD05-C013-498B-BBFE-560AC4D0DFE4 Q36293209-25702E67-7135-49EE-B66D-9ADA22339E5D Q36439912-7BCB5B0F-B6D5-4C42-9CDB-1058BBEDCF2C Q36575243-D2D22051-8E3B-4F84-A7CF-2301556ECDA7 Q36774712-4D19BA24-3B9E-4F5F-968B-F0FBAD7CDF00 Q36827512-852EC666-C911-4FF8-8A25-9C154319EBC8 Q36844904-1F9BB226-BF62-4C03-ABC6-EAE45573012A Q36863089-91CB1C44-D104-4237-8B65-D22E38159A47 Q36878791-DCBF2573-D75A-4CED-B63A-52B439D8C625 Q36951558-D041529E-8488-4A02-A316-5BBBB8CAE9F4 Q36959452-6DE58D6C-EE6D-48BE-9682-8D9BF126E8C0

P2860

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.

http://www.wikidata.org/entity/Q34166215

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@ast

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@en

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@nl

type

label

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@ast

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@en

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@nl

prefLabel

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@ast

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@en

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@nl

P1433

Q34166215-B01F5EA2-D127-43CF-99D3-5F6ABA7F88BD

P1476

Q34166215-FBA657AB-7800-451B-8BA2-E954775AE9C4

P2093

Q34166215-2377CEAB-30F6-46D4-9DDD-434711F6C953

Q34166215-469053E0-68BC-4A51-8100-34CF9E65E879

Q34166215-4838A8D6-BF68-4D18-935E-F5A1F679ED02

Q34166215-4B1DB3BB-9D7E-493F-8BAB-8FBAD08AF135

Q34166215-5CA6FE23-1B57-4CBA-B315-A275F71B0ABA

Q34166215-5F89BCB5-3F8F-4A21-A607-5D6E4C0575EC

Q34166215-7751791A-2EF8-4DA7-A0FE-0BE4478D4598

Q34166215-86774827-D3EA-467D-BCC4-09A181A06017

Q34166215-DC8F8D72-7259-46CC-889E-DF288F706EAD

P304

Q34166215-A8F7563E-DC80-4E2A-8F35-87BF734F3EA8

P31

Q34166215-96DFA5E2-5288-4646-AD22-1B63CCF99FED

P356

Q34166215-8A2D131D-7C40-487C-9C7F-09D54342E97D

P407

Q34166215-7F51AE1E-1214-43B7-B0A1-5C787FCCE5CB

P433

Q34166215-B55FAEB9-BE1B-4072-B425-04D36567EECD

P478

Q34166215-1F95AF17-5699-4AF1-B9B0-93F3F1EE8BC5

P50

Q34166215-0AAEFAAA-7A9A-4A49-B25C-775444014E41

Q34166215-43AD97E6-F5EE-4C9D-9C08-300DAA1F0DA6

Q34166215-4E2F5DD6-3CB4-4237-9F04-D745C671BD09

Q34166215-5124EFC3-497F-4374-9E45-402D0AFEEE53

Q34166215-63C4BCBA-86A8-4F1A-B87C-77DB373D22C1

Q34166215-65CE0B3E-1C8B-4489-82CD-69C3F89A212A

P577

Q34166215-56426EE7-FC8D-46D7-BBED-7250D994F67E

P698

Q34166215-4B8F8DB5-C568-4E3A-8E58-F793B7EE8060

P921

Q34166215-CF0FFEA6-EEFC-4423-A40C-078EA2A9A599

P356

0008-5472.CAN-10-2421

P1433

Cancer Research

P1476

Systematic analysis of microRN ...... ptor in prostate cancer cells.

@en

P2093

Anders Bjartell

http://www.w3.org/2001/XMLSchema#string

Anders Edsjö

http://www.w3.org/2001/XMLSchema#string

Anna Aakula

http://www.w3.org/2001/XMLSchema#string

Daniel Nicorici

http://www.w3.org/2001/XMLSchema#string

Henrik Edgren

http://www.w3.org/2001/XMLSchema#string

Rami Mäkelä

http://www.w3.org/2001/XMLSchema#string

Sara Kangaspeska

http://www.w3.org/2001/XMLSchema#string

Yvonne Ceder

http://www.w3.org/2001/XMLSchema#string

Zandra Hagman

http://www.w3.org/2001/XMLSchema#string

P304

1956-1967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-2421

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Olli-Pekka Kallioniemi

Päivi Östling

Sara Kangaspeska

Suvi-Katri Leivonen

P577

2011-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21343391

http://www.w3.org/2001/XMLSchema#string

P921